Cardio-Kidney-Damage: a unifying concept

Meguid El Nahas1

  • 1Sheffield Kidney Institute, Northern General Hospital, Sheffield, UK. m.el-nahas@sheffield.ac.uk

Insights

The global rise in chronic kidney disease (CKD) may be overstated due to screening issues. High prevalence in the elderly likely reflects age-related cardiovascular issues, not necessarily a distinct disease.

Area of Science:

  • Nephrology
  • Cardiology
  • Geriatrics

Background:

  • Global rise in chronic kidney disease (CKD) perception is debated.
  • Skepticism exists regarding CKD prevalence due to screening methods.
  • Markers like glomerular filtration rate and microalbuminuria have faced criticism.

Purpose of the Study:

  • To reconcile differing views on CKD prevalence.
  • To examine evidence regarding CKD in the elderly population.
  • To investigate the relationship between CKD and cardiovascular disease.

Main Methods:

  • Review of existing evidence on CKD prevalence and definitions.
  • Analysis of screening methods for CKD.
  • Examination of age-related changes in kidney function.

Main Results:

  • High CKD prevalence in the elderly may be linked to atherosclerosis and cardiovascular disease.
  • Age-related decline in kidney function is debated as physiological vs. pathological.
  • Cardio-Kidney-Damage (C-K-D) is proposed as a unifying concept.

Conclusions:

  • CKD in the elderly may reflect underlying cardiovascular conditions.
  • The label 'disease' for age-related kidney decline may not always be appropriate.
  • Focus on cardiovascular risk reduction and careful evaluation is crucial for managing elderly patients.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...